Candidemia in ICU patients with sepsis

Critical Care Medicine

Volumn 41, Issue 11, 2013, Pages

  Gutiérrez, Sandra M ^a   Heredia, María ^a   Gómez, Esther ^a   Gómez, José I ^a   Tamayo, Eduardo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BLOOD CULTURE; CANDIDA; CANDIDEMIA; CLINICAL PRACTICE; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; LETTER; MORBIDITY; MORTALITY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK;

ANTIFUNGAL AGENTS; CANDIDEMIA; HUMANS; INTENSIVE CARE UNITS; SEPSIS;

EID: 84887088061     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182916f76     Document Type: Letter

References (4)

1. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
2. Guzman JA, Tchokonte R, Sobel JD: Septic shock due to candidemia: Outcomes and predictors of shock development. J Clin Med Res 2011; 3:65-71
3. Posteraro B, De Pascale G, Tumbarello M, et al: Early diagnosis of candidemia in intensive care unit patients with sepsis: A prospective comparison of (1?3)-?-d-glucan assay, Candida score, and colonization index. Crit Care 2011; 15:R249
4. Pappas PG, Kauffman CA, Andes D, et al; Infectious Diseases Society of America: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-535